AI-ACCELERATED DRUG DISCOVERY

Receptor.AI will attend Bio-Europe Spring Conference 2024

We are excited to share that our CEO, Dr. Alan Nafiiev, will be attending the BIO-Europe Spring 2024 conference in Barcelona from March 18-20. This event marks a significant opportunity for those deeply invested in the intersection of AI and drug discovery to come together and explore potential collaborations. Dr. Nafiiev is eager to engage in discussions about the future of medicine and the pivotal role AI plays in accelerating the drug discovery process.

We extend an invitation to our partners and other industry professionals specializing in drug discovery to connect with us at this prestigious event. Please feel free to contact us to schedule one-on-one meetings. We look forward to connecting with you in Barcelona and together, pushing the boundaries of what's possible in the field of precision medicine.